慢性阻塞性肺疾病患者血清 sICAM-1、炎性介质的检测及临床意义

牟涌, 蒋春彦

牟涌, 蒋春彦. 慢性阻塞性肺疾病患者血清 sICAM-1、炎性介质的检测及临床意义[J]. 实用临床医药杂志, 2014, (15): 28-31. DOI: 10.7619/jcmp.201415009
引用本文: 牟涌, 蒋春彦. 慢性阻塞性肺疾病患者血清 sICAM-1、炎性介质的检测及临床意义[J]. 实用临床医药杂志, 2014, (15): 28-31. DOI: 10.7619/jcmp.201415009
MOU Yong, JIANG Chunyan. The clinical significance of detection serum sICAM-1, inflammatory mediators levels of patients with chronic obstructive pulmonary disease[J]. Journal of Clinical Medicine in Practice, 2014, (15): 28-31. DOI: 10.7619/jcmp.201415009
Citation: MOU Yong, JIANG Chunyan. The clinical significance of detection serum sICAM-1, inflammatory mediators levels of patients with chronic obstructive pulmonary disease[J]. Journal of Clinical Medicine in Practice, 2014, (15): 28-31. DOI: 10.7619/jcmp.201415009

慢性阻塞性肺疾病患者血清 sICAM-1、炎性介质的检测及临床意义

详细信息
  • 中图分类号: R441.8

The clinical significance of detection serum sICAM-1, inflammatory mediators levels of patients with chronic obstructive pulmonary disease

  • 摘要: 目的:观察和分析慢性阻塞性肺疾病(COPD)患者血清可溶性细胞间黏附分子-1(sICAM-1)、炎性因子检测的临床意义。方法选取 COPD 急性加重期(AECOPD)患者60例作为 AECOPD 组,根据治疗前是否合并呼吸衰竭将其分为合并呼衰组和未合并呼衰组2个亚组;选取同期经常规治疗临床症状缓解的 AECOPD 患者60例作为 COPD 稳定期组;选取同期体检结果健康者60例作为对照组。对3组研究对象的血清 sICAM-1、白细胞介素-10(IL-10)、白细胞介素-18(IL-18)水平进行检测和分析。结果 AECOPD 组患者的血清 sICAM-1和 IL-18水平显著高于 COPD 稳定期组(P <0.05);COPD 稳定期组患者的血清 sICAM-1和 IL-18水平显著高于对照组(P <0.05);AECOPD 组患者的血清 IL-10水平显著低于 COPD 稳定期组(P <0.05);COPD 稳定期组患者的血清 IL-10水平显著低于对照组(P <0.05);合并呼衰组患者的血清 sICAM-1和 IL-18水平显著高于未合并呼衰组(P <0.05);合并呼衰组患者的血清 IL-10水平显著低于未合并呼衰组(P <0.05);AECOPD 组患者的血清 IL-10水平与血清 sICAM-1水平呈负相关关系(r =-0.53,P <0.05),而 AECOPD 组患者的血清 IL-18水平与血清sICAM-1水平呈正相关关系(r =0.68,P <0.05)。结论血清 sICAM-1和 IL-18水平的上升以及血清 IL-10水平的下降可能与 AECOPD 的发生及其合并呼吸衰竭有相关性,血清 sICAM-1水平的上升可反映患者机体炎性反应的加剧状态。
    Abstract: Objective To observe and analyze clinical significance of detection of serum sol-uble intracellular adhesion molecule-1 (sICAM-1),inflammatory mediators levels for the patients with chronic obstructive pulmonary disease (COPD).Methods 60 patients with acute exacerbated COPD were selected as the AECOPD group and divided into complicated with respiratory failure group and the without complicated respiratory failure group according to whether the patients had been complicated with respiratory failure before the treatment;60 patients with AECOPD whose clinical symptoms were relieved after the routine treatment during the same period were selected as the COPD stable phase group;60 patients with healthy examination results during the same period were selected as the control group.The serum levels of sICAM-1,interleukin-10 (IL-10),inter-leukin-18 (IL-18)of the subjects in the three groups were detected and analyzed.Results The serum sICAM-1 and IL-18 levels of the patients in the AECOPD group were significantly higher than those of the COPD stable phase group (P <0.05)and the serum sICAM-1 and IL-18 levels of the patients in the COPD stable phase group were significantly higher than those of the control group (P <0.05);The serum IL-10 level of the patients in the AECOPD group was significantly lower than that of the COPD stable phase group (P <0.05)and the serum IL-10 level of the patients in the COPD stable phase group was significantly lower than that of the control group (P < 0 .0 5 );The serum sICAM-1 and IL-1 8 levels of the patients in the complicated with respiratory failure group were significantly higher than those of the without complicated respirato-ry failure group (P <0.05)and the serum IL-10 level of the patients in the complicated with res-piratory failure group was significantly lower thanthat of the without complicated respiratory fail-ure group (P <0.05);In the AECOPD group,the serum IL-10 level was negative related with the serum sICAM-1 level of (r =-0.53,P <0.05),while the serum IL-18 level was positively related with the serum sICAM-1 level (r =0.68,P <0.05).Conclusion The increased serum sICAM-1 and IL-18 levels and the decreased serum IL-10 level may be associated with the occur-rence of AECOPD and the complicated respiratory failure.The increasing of the serum sICAM-1 level can reflect the state of the inflammatory reaction of patients.
  • 期刊类型引用(5)

    1. 汤思,陈学杰. 直接抗人球蛋白试验阳性分型与输血疗效的相关性. 吉林医学. 2024(02): 295-297 . 百度学术
    2. 杨占甲,李丽娟,宋银森. 多发性骨髓瘤患者红细胞输注效果的影响因素探讨. 中国实用医刊. 2024(13): 66-69 . 百度学术
    3. 梁冬香,钟昌瑞,傅春花,邱启东. 直接抗人球蛋白试验凝集强度的结果分析及临床意义. 临床血液学杂志. 2024(12): 905-908 . 百度学术
    4. 闻才李,张慧,杨吉岳,孙一心,程晓文. 直接抗人球蛋白试验阳性患者298例的病因回顾性分析. 医药论坛杂志. 2022(08): 72-74+78 . 百度学术
    5. 胡泽斌,孙彬裕,孙晶,王布强,于婷. 抗人球蛋白检测卡行业标准的研究. 中国医药生物技术. 2022(05): 449-452 . 百度学术

    其他类型引用(0)

计量
  • 文章访问数:  213
  • HTML全文浏览量:  45
  • PDF下载量:  1
  • 被引次数: 5
出版历程
  • 发布日期:  2014-09-10

目录

    /

    返回文章
    返回
    x 关闭 永久关闭